Skip to content

Diabetes ManagementDiabetes Management

Type 2 diabetes now has medicines from several drug classes, many of them combined into a single tablet, alongside insulin for people who need it. Which class or combination suits a person depends on other health conditions as much as on blood glucose itself, which is why the choice is made with a prescriber.

Metformin Tablets

Metformin

500mg · 850mg

Designed to support glycaemic control to manage diabetes mellitus and address tissue insulin sensitivity.

From$0.24/ tabletView

Rybelsus

Semaglutide

3mg · 7mg · 14mg

Formulated to alleviate elevated blood glucose parameters to support long-term cardiovascular health and manage weight.

From$14.67/ tabletView

Actos

Pioglitazone

15mg · 30mg · 45mg

Utilised to manage glucose concentrations to alleviate chronic hyperglycaemia and support peripheral tissue metabolism.

From$0.81/ tabletView

Amaryl

Glimepiride

1mg · 2mg · 3mg · 4mg

Indicated to address blood sugar levels to manage diabetes symptoms and alleviate glycaemic fluctuations.

From$0.70/ tabletView

Glucotrol Xl

Glipizide

2.5mg · 5mg · 10mg

Indicated to address chronic blood glucose levels to support metabolic optimisation and manage diabetic complications.

From$0.16/ tabletView

Glucovance

Metformin, Glibenclamide

2.5mg + 400mg · 5mg + 500mg

Formulated to alleviate chronic hyperglycaemia to support glycaemic control and target insulin resistance.

From$1.16/ tabletView

Victoza

Liraglutide

6mg

Formulated to alleviate elevated blood glucose parameters to support long-term metabolic health and manage weight.

From$401.50/ auto-injectorView

Cozaar

Losartan

25mg · 50mg · 100mg

Designed to support arterial pressure management to manage renal filtration and alleviate vascular tension.

From$0.73/ tabletView

Dapasmart

Dapagliflozin

5mg · 10mg

Intended to relieve high blood sugar levels to support glycaemic targets and target renal excretion pathways.

From$3.75/ tabletView

Jentadueto Xr

Linagliptin, Metformin

5mg + 1000mg

Developed to mitigate elevated blood glucose to support long-term metabolic health and target insulin receptor action.

From$1.90/ tabletView

Tradjenta

Linagliptin

10mg

Developed to mitigate blood glucose parameters to support long-term metabolic health and target insulin secretion.

From$2.19/ tabletView

Invokana

Canagliflozin

100mg

Indicated to address elevated blood glucose to manage diabetes symptoms and alleviate glycaemic strain.

From$4.82/ tabletView

Nesina

Alogliptin

12.5mg · 25mg

Indicated to address glucose concentrations to manage type 2 diabetes and alleviate postprandial sugar spikes.

From$1.08/ tabletView

Prandin

Repaglinide

0.5mg · 1mg · 2mg

Indicated to address postprandial glycaemic elevations to manage type 2 diabetes and support mealtime insulin release.

From$1.67/ tabletView

Precose

Acarbose

25mg · 50mg

Designed to support postprandial sugar management to manage diabetes symptoms and alleviate glucose absorption.

From$1.32/ tabletView

Glyset

Miglitol

50mg

Intended to relieve postprandial blood sugar spikes to support long-term diabetes management and target carbohydrate absorption.

From$2.17/ tabletView

Micronase

Glibenclamide

2.5mg · 5mg

Intended to relieve chronic blood sugar elevations to support endocrine balance and target pancreatic beta cells.

From$0.54/ tabletView

Avandia

Rosiglitazone

2mg · 4mg

Formulated to alleviate chronic hyperglycaemia to support glycaemic target maintenance and target cell receptor sensitivity.

From$1.29/ tabletView

Hsquin

Hydroxychloroquine

200mg · 300mg · 400mg

Indicated to address autoimmune and parasitic conditions to manage physical joint pain and support systemic tissue healing.

From$0.53/ tabletView

Ddavp Spray

Desmopressin

10mcg 2.5ml

Designed to support water retention to manage central diabetes insipidus and alleviate nighttime bedwetting.

From$70.13/ sprayView

Jentadueto

Linagliptin, Metformin

2.5mg + 500mg

Indicated to manage glycaemic control in adults and developed to support blood glucose reduction in type 2 diabetes.

From$1.37/ tabletView

Metaglip

Glipizide, Metformin

2.5mg + 500mg · 5mg + 500mg

Formulated to manage type 2 diabetes mellitus, this combined therapy is utilised to support blood glucose control and to mitigate glycaemic fluctuations.

From$0.47/ tabletView

Sitagliptin Tablets

Sitagliptin

50mg · 100mg

Inhibits DPP-4 to enhance incretin hormones, improving glycaemic control in type 2 diabetes mellitus by increasing insulin secretion and decreasing glucagon in a glucose-dependent manner.

From$2.71/ tabletView

Key points

  • NIDDK notes that people with type 1 diabetes need insulin because the pancreas no longer produces it.
  • NICE’s guidance on initial medicines for type 2 diabetes includes metformin alongside several other oral drug classes.
  • NICE also discusses SGLT-2 inhibitors and GLP-1 receptor agonists for their cardiovascular and kidney effects, not only blood glucose.

Oral medicines for type 2 diabetes

Metformin Tablets contain metformin, used alone or combined with another ingredient in brands such as Metaglip, Jentadueto and Glucovance. Amaryl, Glucotrol XL and Micronase contain the sulfonylureas glimepiride, glipizide and glibenclamide. Tradjenta, Nesina and Sitagliptin Tablets contain the DPP-4 inhibitors linagliptin, alogliptin and sitagliptin, while Invokana, Dapasmart and Empagliflozin Tablets contain the SGLT-2 inhibitors canagliflozin, dapagliflozin and empagliflozin; Dapasmart is also used for heart failure and chronic kidney disease, and Empagliflozin Tablets for heart failure and reducing cardiovascular mortality risk. Glyxambi combines empagliflozin with linagliptin, and Actos, Avandia, Precose, Glyset and Prandin contain pioglitazone, rosiglitazone, acarbose, miglitol and repaglinide.

Insulin and the incretin medicines

Insulin Glargine Injection contains insulin glargine, given by injection for diabetes mellitus. Victoza contains liraglutide, also given by injection, while Rybelsus contains semaglutide as a tablet instead, unusual for a class of medicine that is otherwise injected.

Why DDAVP Spray, Hsquin and Cozaar are not diabetes treatments

DDAVP Spray contains desmopressin, used for central diabetes insipidus and primary nocturnal enuresis (bedwetting); diabetes insipidus is a separate condition from diabetes mellitus and is not related to blood glucose despite the similar name. Hsquin contains hydroxychloroquine, used for rheumatoid arthritis, systemic lupus erythematosus and malaria prevention, none of which relate to diabetes. Cozaar contains losartan, a blood pressure medicine also used for diabetic nephropathy and stroke prevention; it treats a complication that can follow diabetes rather than diabetes itself.

Further reading

Related articles